Evidence map›Paper›PMID 40786352›Full record

ArticleCureus2025

Spontaneous Psoas Hematoma Following Resistance Training in an Elderly Patient on Apixaban: A Case Report.

Violeta Foss, Taner B Celebi, Rafeh Waheed, Herman Dhillon

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Violeta FossFamily Medicine, Northwell Health, Plainview, USA.
Taner B CelebiFamily Medicine, Northwell Health, Plainview, USA.
Rafeh WaheedFamily Medicine, Northwell Health, Plainview, USA.
Herman DhillonRadiology, Northwell Health, Manhasset, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regular physical activity, including resistance training, is strongly recommended for older adults to preserve muscle mass, balance, and functional independence. However, the increasing use of direct oral anticoagulants (DOACs), such as apixaban, in this population introduces important clinical considerations, particularly the risk of spontaneous bleeding in those participating in physical activity. Various scoring systems are used to create better judgement calls when initiating an anticoagulant, however initiating the anticoagulant is up to the discretion of the physician. We present the case of an 80-year-old male with multiple comorbidities, including atrial fibrillation managed on apixaban for anticoagulation, who was diagnosed with a spontaneous psoas hematoma during hospitalization for pneumonia. This case highlights the importance of a risk-aware approach to physical activity counseling in older adults on anticoagulation therapy. Clinicians must maintain a high index of suspicion and provide tailored exercise guidance to minimize injury risk. As the older population and use of DOACs continue to rise, increased awareness and surveillance are essential to promote safe physical activity in this vulnerable group.

Indexed as

atrial fibrillation (afib): direct oral anticoagulants (doac)exercise trainingiliopsoas hematomaoral anticoagulation

Identifiers

PMID40786352
PMCPMC12335901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.